CRBU - Caribou Biosciences - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CRBU is currently covered by 2 analysts with an average price target of $13.17. This is a potential upside of $11.23 (578.87%) from yesterday's end of day stock price of $1.94.

Caribou Biosciences's activity chart (see below) currently has 58 price targets and 66 ratings on display. The stock rating distribution of CRBU is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 12.12% with an average time for these price targets to be met of 10 days.

Highest price target for CRBU is $9, Lowest price target is $8, average price target is $8.5.

Most recent stock forecast was given by ROBERT BURNS from HC WAINWRIGHT on 05-Nov-2025. First documented stock forecast 17-Aug-2021.

Currently out of the existing stock ratings of CRBU, 5 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 01-Dec-2021

$9

$7.22 (405.62%)

$6.92

4 months 29 days ago
(05-Nov-2025)

0/12 (0%)

$6.81 (310.96%)

Buy Since 14-Nov-2021

$8

$6.22 (349.44%)

$5

5 months ago
(03-Nov-2025)

1/11 (9.09%)

$5.57 (229.22%)

1

Buy Since 17-Feb-2022

$11

$9.22 (517.98%)

1 years 23 days ago
(11-Mar-2025)

0/5 (0%)

$9.93 (928.04%)

Buy Since 11-Jul-2023

1 years 7 months ago
(03-Sep-2024)

0/2 (0%)

$15.26 (265.85%)

Hold Since 03-Jun-2024

$3

$1.22 (68.54%)

$13

1 years 10 months ago
(03-Jun-2024)

0/2 (0%)

$0.85 (39.53%)

Show more analysts

Please expand the browser size to see the chart

What is CRBU (Caribou Biosciences) average time for price targets to be met?

On average it took 10 days on average for the stock forecasts to be realized with a an average price target met ratio 12.12

Which analyst has the current highest performing score on CRBU (Caribou Biosciences) with a proven track record?

YIGAL NOCHOMOVITZ

Which analyst has the current lower performing score on CRBU (Caribou Biosciences) with a proven track record?

LIISA BAYKO

Which analyst has the most public recommendations on CRBU (Caribou Biosciences)?

Yigal Nochomovitz works at CITI and has 29 price targets and 20 ratings on CRBU

Which analyst is the currently most bullish on CRBU (Caribou Biosciences)?

Mani Foroohar with highest potential upside - $32.22

Which analyst is the currently most reserved on CRBU (Caribou Biosciences)?

Mark Breidenbach with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?